Douglas H. Thamm on Muck Rack

Douglas H. Thamm

  • Barbara Cox Anthony Professor of Oncology, Colorado State University
Fort Collins
As seen in: Color Research & Application, Nature, Veterinary and Comparative Oncology, Wiley, Wiley Online Library, SAGE Publishing, ACS Publications, American Veterinary Medical Association [AVMA]
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Douglas H.

Contact Douglas H., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Comparative genomic and clinicopathological analysis uncovers contrasting molecular profiles of canine and human thyroid carcinomas - Communications Biology

|
By Sunetra Das, Samantha N. Schlemmer, Daniel Regan, Douglas H. Thamm
| Nature Verified
Abstract Thyroid tumors represent 1–4% of cancers in both dogs and humans. Most canine tumors are follicular (FTC) or medullary carcinomas (MTC), unlike humans, where only 10–15% are FTC and 2% are MTC, with BRAF/NRAS or RET mutations, respectively. Here, we conduct histological and molecular analyses of canine thyroid tumors. Transcriptionally, elevated ERBB2 expression characterizes FTC tumors, whereas MTC tumors show upregulated RET signaling.
Open in Who Shared Issue with article?

High specificity and sensitivity of spot urine normetanephrine-to-creatinine ratios in the diagnosis of canine pheochromocytoma

|
By Carly Waldron, Douglas H. Thamm, Arathi Vinayak, Maegan Watson-Skaggs
| American Veterinary Medical Association [AVMA]
Share Link Copy this link, or click below to email it to a friend or copy the link directly: The link was not copied. Your current browser may not support copying via this button.
Open in Who Shared View Duplicates (26) Issue with article?

Review: The PI3K-AKT-mTOR signal transduction pathway in canine cancer

|
By Travis Meuten, Gregg A. Dean, Douglas H. Thamm
| SAGE Publishing
Skip to main content Intended for healthcare professionals Get full access to this article View all access and purchase options for this article. References 1. Adachi M, Hoshino Y, Izumi Y, et al. Effects of inhibitors of vascular endothelial growth factor receptor 2 and downstream pathways of receptor tyrosine kinases involving phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin or mitogen-activated protein kinase in canine hemangiosarcoma cell lines. Can J Vet Res. 2016;80:209–216. 2.
Open in Who Shared Issue with article?
See all 23 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified